Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Risks of presymptomatic direct-to-consumer genetic testing.

Literature DB >> 20843242

Risks of presymptomatic direct-to-consumer genetic testing.

Justin P Annes¹, Monica A Giovanni, Michael F Murray.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2010 PMID： 20843242 PMCID： PMC8806904 DOI： 10.1056/NEJMp1006029

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

× No keyword cloud information.

2 in total

1. Promoting safe and effective genetic tests in the United States: work of the task force on genetic testing.

Authors: N A Holtzman
Journal: Clin Chem Date: 1999-05 Impact factor: 8.327

2. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years.

Authors: Anne Andermann; Ingeborg Blancquaert; Sylvie Beauchamp; Véronique Déry
Journal: Bull World Health Organ Date: 2008-04 Impact factor: 9.408

2 in total

20 in total

1. Multilevel research and the challenges of implementing genomic medicine.

Authors: Muin J Khoury; Ralph J Coates; Mary L Fennell; Russell E Glasgow; Maren T Scheuner; Sheri D Schully; Marc S Williams; Steven B Clauser
Journal: J Natl Cancer Inst Monogr Date: 2012-05

2. Understanding FDA regulation of DTC genetic tests within the context of administrative law.

Authors: Jennifer K Wagner
Journal: Am J Hum Genet Date: 2010-10-08 Impact factor: 11.025

3. Perception of direct-to-consumer genetic testing and direct-to-consumer advertising of genetic tests among members of a large managed care organization.

Authors: Alanna Kulchak Rahm; Heather Spencer Feigelson; Nicole Wagner; Anh Quynh Le; Eve Halterman; Nadine Cornish; James W Dearing
Journal: J Genet Couns Date: 2012-01-26 Impact factor: 2.537

Risks of presymptomatic direct-to-consumer genetic testing.

1. Promoting safe and effective genetic tests in the United States: work of the task force on genetic testing.

2. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years.

1. Multilevel research and the challenges of implementing genomic medicine.

2. Understanding FDA regulation of DTC genetic tests within the context of administrative law.

3. Perception of direct-to-consumer genetic testing and direct-to-consumer advertising of genetic tests among members of a large managed care organization.

Review 4. Direct-to-consumer personalized genomic testing.

5. Predictors of adverse psychological experiences surrounding genome-wide profiling for disease risk.

6. In Defense of Direct-to-Consumer Genetic Testing.

Review 7. The pharmacogenetics of antiplatelet agents: towards personalized therapy?

Review 8. The genetics of common kidney disease: a pathway toward clinical relevance.

9. Time for physicians to be aware of molecular genetic testing. Report from the 3rd Viareggio Health Festival.

10. Association between health-service use and multiplex genetic testing.